Quantitative assessment of the association between XRCC1 Arg399Gln and Arg194Trp polymorphisms and risk of cutaneous melanoma.

Abstract:

:Accumulating evidence has suggested that the XRCC1 Arg399Gln and Arg194Trp polymorphisms might be related to cutaneous melanoma susceptibility. However, epidemiologic findings have been inconsistent. We have assessed reported studies by meta-analysis to perform a more precise estimation of the association between the XRCC1 two polymorphisms (Arg399Gln, Arg194Trp) and risk of cutaneous melanoma. A total of seven eligible articles were selected for this meta-analysis, including 3454 cases and 3811 controls for the XRCC1 Arg399Gln polymorphism and 1256 cases and 1575 controls for the XRCC1 Arg194Trp polymorphism. Overall, no significant associations were found in all genetic models when the studies were pooled into the meta-analysis for the Arg399Gln and Arg194Trp polymorphisms. When stratified by source of control, significant associations were found for the Arg399Gln polymorphism in the population-based subgroup under AA versus GG [odds ratio (OR)=1.43, 95% confidence interval (CI)=1.08-1.88]; the dominant model AA/GA versus GG (OR=1.25, 95% CI=1.04-1.51); and the recessive model AA versus GA/GG (OR=1.31, 95% CI=1.01-1.68). No significant associations were found for the Arg194Trp polymorphism in the subgroup analysis. This meta-analysis suggested that the XRCC1 Arg399Gln polymorphism was a risk factor for cutaneous melanoma in population-based subgroup.

journal_name

Melanoma Res

journal_title

Melanoma research

authors

Jiang H,Xu W,Zhang F,Wei L,Wang Y,Wang Y,Liu C

doi

10.1097/CMR.0000000000000246

subject

Has Abstract

pub_date

2016-06-01 00:00:00

pages

290-9

issue

3

eissn

0960-8931

issn

1473-5636

journal_volume

26

pub_type

杂志文章,meta分析
  • Exploring metabolic reprogramming in melanoma via acquired resistance to the oxidative phosphorylation inhibitor phenformin.

    abstract::Therapeutic failures in cancer therapy are often associated with metabolic plasticity. The use of metabolic modulators as anti-cancer agents has been effective in correcting metabolic alterations; however, molecular events behind metabolic switch are still largely unexplored. Herein, we characterize the molecular and ...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000624

    authors: Pistoni M,Tondelli G,Gallo C,Torricelli F,Maresca A,Carelli V,Ciarrocchi A,Dallaglio K

    更新日期:2020-02-01 00:00:00

  • Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial.

    abstract::The aim of this study was to evaluate the accuracy of a computer-based system for the automated diagnosis of melanoma in the hands of nonexpert physicians. We performed a prospective comparison between nonexperts using computer assistance and experts without assistance in the setting of a tertiary referral center at a...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0b013e32832a1e41

    authors: Dreiseitl S,Binder M,Hable K,Kittler H

    更新日期:2009-06-01 00:00:00

  • Prognosis of endoscopic surgery and traditional open resection in mucosal melanoma of the nasal cavity and paranasal sinus.

    abstract::Mucosal melanoma of the nasal cavity and paranasal sinus is always associated with poor prognosis, and 5-year overall survival does not exceed 40%. Our study aimed to compare the intraoperative conditions and prognosis of different surgical techniques to determine the optimum surgical approach for patients with mucosa...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000516

    authors: Yin G,Guo W,Chen X,Huang Z

    更新日期:2019-02-01 00:00:00

  • Expression of angiogenic and immunosuppressive factors by uveal melanoma cell lines.

    abstract::Dissemination of uveal melanomas is almost exclusively haematogenous, making angiogenesis of the tumour a prerequisite for the formation of metastases. Uveal melanomas must employ strategies to evade the immune system in order to escape immune surveillance. We therefore determined the expression of the following angio...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-199910000-00003

    authors: Ijland SA,Jager MJ,Heijdra BM,Westphal JR,Peek R

    更新日期:1999-10-01 00:00:00

  • Determinants of acute regional toxicity following isolated limb perfusion for melanoma.

    abstract::Hyperthermic isolated limb perfusion (ILP) with melphalan is well established as an effective form of treatment for recurrent melanoma confined to an extremity. High drug concentrations in the limb are readily achieved, without systemic side-effects. However, regional toxicity can lead to considerable morbidity and fu...

    journal_title:Melanoma research

    pub_type: 临床试验,杂志文章

    doi:10.1097/00008390-199606000-00010

    authors: Thompson JF,Eksborg S,Kam PC,Ingvar C,Yau DF,Lai DT,Ramzan I

    更新日期:1996-06-01 00:00:00

  • Parallel risk assessment of melanoma and basal cell carcinoma: skin characteristics and sun exposure.

    abstract::In this study we compared the strength of the association of constitutional factors and sun exposure with cutaneous malignant melanoma (CMM) and basal cell carcinoma (BCC). We analysed 260 incident cases of CMM, 425 incident cases of BCC and two sets of population controls from previous case-control studies conducted ...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-199812000-00013

    authors: Rosso S,Zanetti R,Pippione M,Sancho-Garnier H

    更新日期:1998-12-01 00:00:00

  • Ipilimumab for advanced melanoma: experience from the Spanish Expanded Access Program.

    abstract::Ipilimumab, a fully human, recombinant, monoclonal antibody to cytotoxic T-lymphocyte antigen 4 improves overall survival (OS) in previously treated and untreated metastatic melanoma. This retrospective analysis reports data gathered by a questionnaire on the demographics, outcomes, and toxicity of ipilimumab administ...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000108

    authors: Berrocal A,Arance A,Lopez Martin JA,Soriano V,Muñoz E,Alonso L,Espinosa E,Lopez Criado P,Valdivia J,Martin Algarra S,Spanish Melanoma Group.

    更新日期:2014-12-01 00:00:00

  • Fatty acid receptor GPR120: a novel marker for human melanoma.

    abstract::The correlation between ultraviolet radiation of the skin and melanoma incidence in humans is well established. Interestingly, epidemiologic data suggest also a correlation to an increased BMI pointing to metabolic trigger factors in melanoma pathogenesis. To substantiate this connection, we studied the expression of ...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000445

    authors: Kleemann J,Hrgovic I,Ter-Nedden J,Kleimann P,Steinhorst K,Härle K,Müller J,Kaufmann R,Meissner M,Kippenberger S

    更新日期:2018-08-01 00:00:00

  • Routine retrieval of pelvic sentinel lymph nodes for melanoma rarely adds prognostic information or alters management.

    abstract::Pelvic sentinel lymph nodes (SLNs) are commonly identified during inguinal SLN biopsy for melanoma, but retrieval is not uniform among surgeons/centers. Few studies have assessed rates of micrometastases in pelvic versus superficial inguinal SLNs. Previous studies suggested that presence of pelvic SLNs was predicted b...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000498

    authors: Swords DS,Andtbacka RHI,Bowles TL,Hyngstrom JR

    更新日期:2019-02-01 00:00:00

  • Synchronous high-risk melanoma and lymphoid neoplasia.

    abstract::Large population-based studies have shown a significant association between melanoma and lymphoid neoplasia, particularly non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukaemia (CLL), that is independent of any treatment received for the initial tumour. This study examines the presentation, diagnosis, treatmen...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-200110000-00012

    authors: Cahill RA,McGreal G,Neary P,Redmond HP

    更新日期:2001-10-01 00:00:00

  • Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival?

    abstract::The aim of this study was to determine the impact of complete response (CR) to systemic therapy on survival. We reviewed the cases of 647 chemo-naive patients with metastatic melanoma who were treated with cisplatin-vinblastine-dacarbazine or cisplatin-taxol-dacarbazine alone, or cisplatin-vinblastine-dacarbazine toge...

    journal_title:Melanoma research

    pub_type: 杂志文章,评审

    doi:10.1097/CMR.0b013e328341445f

    authors: Bedikian AY,Johnson MM,Warneke CL,Papadopoulos NE,Kim KB,Hwu WJ,McIntyre S,Rohlfs M,Homsi J,Hwu P

    更新日期:2011-02-01 00:00:00

  • Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients.

    abstract::High-dose cisplatin regimens have been shown to be highly active in advanced melanoma patients but are associated with unacceptable side effects. In order to increase the platinum dose but avoid severe side effects, we treated 15 dacarbazine (DTIC)-resistant metastatic melanoma patients with a combination regimen of c...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-200108000-00012

    authors: Güven K,Kittler H,Wolff K,Pehamberger H

    更新日期:2001-08-01 00:00:00

  • Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome.

    abstract::The liver is the predominant site of metastases in the majority of patients with uveal melanoma, suggesting the evaluation of regional treatment approaches. Here we report our experience with transarterial chemoembolization (TACE) in uveal melanoma patients with pretreated liver metastases. Twenty-five patients were t...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0b013e328334c36e

    authors: Schuster R,Lindner M,Wacker F,Krössin M,Bechrakis N,Foerster MH,Thiel E,Keilholz U,Schmittel A

    更新日期:2010-06-01 00:00:00

  • The heterogeneity of tumor-infiltrating CD8+ T cells in metastatic melanoma distorts their quantification: how to manage heterogeneity?

    abstract::CD8 T-cell infiltration of metastatic melanoma may be a useful biomarker for prediction of prognosis and response to therapy. The heterogeneous distribution of CD8 T cells within a single tumor, and across different tumors within a single patient, may complicate quantification of infiltration. However, the impact of h...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000330

    authors: Obeid JM,Hu Y,Erdag G,Leick KM,Slingluff CL Jr

    更新日期:2017-06-01 00:00:00

  • Response to targeted therapy in two patients with metastatic melanoma carrying rare BRAF exon 15 mutations: A598_T599insV and V600_K601delinsE.

    abstract::Concurrent BRAF-MEK inhibition improves clinical outcomes in patients with advanced BRAF V600E/K-mutant melanoma. There is currently less evidence for the efficacy of this treatment in patients with rare BRAF non-V600E/K genotypes. We report on two patients with rare BRAF exon 15 mutations - BRAF A598_T599insV and V60...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000376

    authors: Rogiers A,Vander Borght S,Tuand K,Wolter P,Stas M,Boecxstaens V,Garmyn M,van den Oord JJ,Vandenberghe P,Bechter O

    更新日期:2017-10-01 00:00:00

  • Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy).

    abstract::Electroporation therapy (EPT) is a novel treatment modality that uses brief, high-intensity, pulsed electrical currents to enhance the uptake of chemotherapeutic agents, vaccines and genes into cells. This technique is potentially useful for patients with secondary and, possibly, some primary tumours. Nineteen patient...

    journal_title:Melanoma research

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1097/00008390-200502000-00008

    authors: Byrne CM,Thompson JF,Johnston H,Hersey P,Quinn MJ,Michael Hughes T,McCarthy WH

    更新日期:2005-02-01 00:00:00

  • 20-year assessment of metastatic latency and subsequent time to death after proton therapy for uveal melanomas.

    abstract::The aim of this study was to evaluate metastatic latency and survival after the occurrence of metastases in patients with choroidal/ciliary body melanoma treated with proton therapy. This was a retrospective cohort study. All consecutive patients with choroidal/ciliary body melanoma treated with proton therapy between...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000519

    authors: Bellocq D,Roy P,Kodjikian L,Mathis T,Nguyen AM,Herault J,Rivoire M,Négrier S,Thariat J,Grange JD

    更新日期:2020-06-01 00:00:00

  • Surgical management of metastatic melanoma in the era of targeted systemic therapies.

    abstract::Treatment strategies for metastatic melanoma have changed markedly in recent times due to the advent of targeted systemic therapies. In addition to these developments, surgery remains a useful adjunct that can confer survival benefits in selected patients. In this review, we examine the current literature to highlight...

    journal_title:Melanoma research

    pub_type: 杂志文章,评审

    doi:10.1097/CMR.0000000000000128

    authors: O'Leary DP,Byrnes KG,Power DG,Redmond HP

    更新日期:2015-02-01 00:00:00

  • Responses to ultraviolet-B in cell lines from hereditary melanoma kindreds.

    abstract::Ultraviolet-B (UV-B) triggers a cascade of events involving cell cycle control genes leading ultimately to DNA repair or apoptosis. The hypothesis examined here is that the genetic abnormality predisposing to melanoma affects the ability of the cell to respond appropriately to UV-B, so favouring mutagenesis. Epstein-B...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-200102000-00001

    authors: Shannon JA,Kefford RF,Mann GJ

    更新日期:2001-02-01 00:00:00

  • Ipilimumab-induced acute severe colitis treated by infliximab.

    abstract::Ipilimumab (anti-CTLA-4 antibody) is a new tool for the treatment of metastatic melanoma patients that has led to an improvement in survival rates worldwide. New types of toxicities have been described with ipilimumab called 'immune-related adverse events' or irAEs. Here, we report an acute and steroid resistant case ...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0b013e32835fb524

    authors: Pagès C,Gornet JM,Monsel G,Allez M,Bertheau P,Bagot M,Lebbé C,Viguier M

    更新日期:2013-06-01 00:00:00

  • Sentinel lymph node dissection in stage I/II melanoma patients: surgical management and clinical follow-up study.

    abstract::Selective sentinel lymph node (SLN) dissection is widely used in the management of cutaneous melanoma patients without clinical evidence of nodal metastases. A series of 274 consecutive melanoma patients who underwent melanoma primary excision and SLN mapping at our institutions since 1998, and were thereafter followe...

    journal_title:Melanoma research

    pub_type: 临床试验,杂志文章

    doi:10.1097/00008390-200404000-00016

    authors: Macripò G,Quaglino P,Caliendo V,Ronco AM,Soltani S,Giacone E,Pau S,Fierro MT,Bernengo MG

    更新日期:2004-04-01 00:00:00

  • Overexpression of HER-2 in thick melanoma.

    abstract::In this study we evaluated the overexpression status of HER-2 and its prognostic significance on survival in patients with thick cutaneous malignant melanoma. The immuno-alkaline phosphatase antigen detection technique was applied to archival diagnostic material from 51 patients with primary lesions measuring >or= 10 ...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-200204000-00006

    authors: Eliopoulos P,Mohammed MQ,Henry K,Retsas S

    更新日期:2002-04-01 00:00:00

  • Accuracy of sentinel lymph node dissection for melanoma staging in the presence of a collision tumour with a lymphoproliferative disease.

    abstract::Sentinel lymph node dissection (SLND) identifies melanoma patients with metastatic disease who would benefit from radical lymph node dissection (RLND). Rarely, patients with melanoma have an underlying lymphoproliferative disease, and melanoma metastases might develop as collision tumours in the sentinel lymph node (S...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000098

    authors: Gero D,Queiros da Mota V,Boubaker A,Berthod G,de Leval L,Demartines N,Matter M

    更新日期:2014-08-01 00:00:00

  • Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases.

    abstract::Microsatellite instability (MSI) is caused by replication errors due to deficient DNA mismatch repair and has been associated with tumour progression in various types of cancer. Controversial results have been reported concerning the frequency and significance of MSI in malignant melanoma. In this study, the time of o...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-200304000-00009

    authors: Palmieri G,Ascierto PA,Cossu A,Colombino M,Casula M,Botti G,Lissia A,Tanda F,Castello G

    更新日期:2003-04-01 00:00:00

  • Superficial spreading melanoma: an analysis of 97 702 cases using the SEER database.

    abstract::Superficial spreading melanoma (SSM) is the most common type of melanoma. Large, population-based studies analyzing the incidence and survival of SSM are limited. This retrospective study was designed to evaluate demographic factors influencing the incidence and survival of SSM using a national population-based databa...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000245

    authors: Singh P,Kim HJ,Schwartz RA

    更新日期:2016-08-01 00:00:00

  • Optimization of intracerebral tumour protection by active-specific immunization against murine melanoma B16/G3.12.

    abstract::Development of brain metastases despite extracerebral response to systemic immunotherapy is a common problem in melanoma patients. We have previously described a murine melanoma vaccine of interferon-gamma (IFNgamma)-treated, irradiated syngeneic B16/G3.12 and allogeneic (Cloudman) melanoma cells, plus the adjuvant DE...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-200108000-00002

    authors: Staib L,Harel W,Mitchell MS

    更新日期:2001-08-01 00:00:00

  • A novel germline variant in the DOT1L gene co-segregating in a Dutch family with a history of melanoma.

    abstract::A proportion of patients diagnosed with melanoma has a positive family history. Despite increasing knowledge on the genes responsible for familial clustering, the genetic basis in the majority of the families with an inherited predisposition to melanoma remains to be clarified. To identify novel melanoma-susceptibilit...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000640

    authors: Salgado C,Kwesi-Maliepaard EM,Jochemsen AG,Visser M,Harland M,van Leeuwen F,van Doorn R,Gruis N

    更新日期:2019-12-01 00:00:00

  • A novel KRAS mutation in metastasic conjunctival melanoma: a case report and literature review.

    abstract::Conjunctival melanoma is a rare disease, and little is known about its molecular background. Here, we present the case of a 48-year-old patient with conjunctival melanoma and metachronic lymph node and skin metastasis with KRAS p.K117Y mutation in exon 4 in all the lesions. The cancer genome interpreter predicted this...

    journal_title:Melanoma research

    pub_type: 杂志文章,评审

    doi:10.1097/CMR.0000000000000423

    authors: Del Carpio Huerta LP,Mas Castells M,Anguera Palacios G,Sullivan I,Gonzalez Vidal A,Majem Tarruella M

    更新日期:2018-04-01 00:00:00

  • Comparison of eumelanin and pheomelanin content between cultured uveal melanoma cells and normal uveal melanocytes.

    abstract::Levels of eumelanin (EM) and pheomelanin (PM) of uveal melanoma cells have not been measured and compared with those of normal uveal melanocytes. EM and PM amounts in four immortal human uveal melanoma cell lines were measured by chemical degradation and microanalytical high-performance liquid chromatography and compa...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0b013e328329ae49

    authors: Hu DN,Wakamatsu K,Ito S,McCormick SA

    更新日期:2009-04-01 00:00:00

  • Effect of Sideritis leptoclada against HT-144 human malignant melanoma.

    abstract::Sideritis leptoclada O. Schwarz et P.H. Davis extracts were evaluated for its singlet oxygen production capacity using spectrophotometric method. The extracts producing singlet oxygen were then evaluated for cytotoxicity against malignant melanoma cancer (HT-144) and fibroblast (3T3) cell lines using the 3-[4,5-dimeth...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000487

    authors: Aydoğmuş-Öztürk F,Günaydin K,Öztürk M,Jahan H,Duru ME,Choudhary MI

    更新日期:2018-12-01 00:00:00